期刊
JOURNAL OF NEURAL TRANSMISSION
卷 122, 期 4, 页码 505-521出版社
SPRINGER WIEN
DOI: 10.1007/s00702-014-1288-x
关键词
Alzheimer disease; Cerebral multimorbidity; Neurodegenerative disease; Proteinopathy; Cerebrovascular lesions; Mixed pathology
A major problem in elderly patients is the high incidence of multiple pathologies, referred to as multimorbidity, in the aging brain. It has been increasingly recognized that co-occurrence of neurodegenerative proteinopathies and other pathologies including cerebrovascular disorders is a frequent event in the brains of both cognitively intact and impaired aged subjects. Although clinical and neuropathological diagnostic criteria of the major neurodegenerative diseases have been improved, major challenges arise from cerebral multimorbidity, and the thresholds to cause clinical overt dementia are ill defined. More than 80 % of aged human brains show neurodegenerative non-Alzheimer type proteinopathies and other pathologies which, however, frequently have been missed clinically and are even difficult to identify at neuropathological examination. Autopsy studies differ in selection criteria and the applied evaluation methods. Therefore, irrespective of the clinical symptoms, the frequency of cerebral pathologies vary considerably: Alzheimer-related pathology is seen in 19-100 %, with pure Alzheimer's disease (AD) in 17-72 %, Lewy pathology in 6-39 % (AD + Lewy disease 9-28 %), vascular pathologies in 28-93 % (10.7-78 % pure vascular dementia), TDP-43 proteinopathy in 6-39 %, hippocampal sclerosis in 8-1 %, and mixed pathologies in 10-93 %. These data clearly suggest that pathologically deposited proteins in neurodegenerating diseases mutually interact and are influenced by other factors, in particular cardiovascular and cerebrovascular ones, to promote cognitive decline and other clinical symptoms. It is obvious that cognitive and other neuropsychiatric impairment in the aged result from a multimorbid condition in the CNS rather than from a single disease and that the number of complex pathologies progresses with increasing age. These facts have implications for improvement of the clinical diagnosis and prognosis, the development of specific biomarkers, preventive strategies and better treatment of cerebral multimorbidity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据